Holcomb John Bradley (CIK 2092279) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy INKT (1,233 shares), Buy INKT (1,239 shares), Buy INKT (1,091 shares), Buy INKT (1,128 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,233 | $13,501 |
| 2026-06-02 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,239 | $13,505 |
| 2026-06-02 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,091 | $13,507 |
| 2025-12-03 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,128 | $12,510 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02